Conviction
$ Value
—
Shares
24,300
Price
—
Filed
Mar 24
▶ Why this score? (9/10)
- ✓ Open market buy (+3)
- ✓ C-suite insider (+2)
- ✓ Director (+1)
- ✓ Cluster: 3 insiders buying (+2)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Bagai Shaun
Title
Chief Executive Officer
CIK
0001862613
Roles
Transaction Details
Transaction Date
2026-03-20
Code
P
Table
Non-Derivative
Ownership
Indirect
Equity Swap
No
Shares After
313,357
Footnotes
The securities were purchased in a private placement on March 20, 2026 for an aggregate of $25,000. | The warrants are exercisable immediately upon issuance and expire on the earlier of (i) March 30, 2029 or (ii) 30 days following the date the Issuer reports at least $1.5 million in product sales revenue (excluding licensing fees, upfront milestones and grants, but including royalty revenue from product sales) for any calendar quarter in a quarterly or annual report. | 289,057 shares of common stock are held of record by The Bagai Family Trust and were previously reported as "directly" beneficially held by the Reporting Person.
Filing Info
Bagai Shaun's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-03 | RNXT | A | $0 |
| 2026-03-20 | RNXT | ▲ | — |
| 2026-03-20 | RNXT | ▲ | — |
| 2025-12-18 | RNXT | ▲ | $5K |
| 2025-12-17 | RNXT | ▲ | $4K |
| 2025-08-25 | RNXT | ▲ | $5K |
| 2025-08-22 | RNXT | ▲ | $5K ★ |
| 2025-07-01 | RNXT | A | $0 |
Other Insiders at RNXT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
VOLL MARK
Chief Financial Officer
|
— | — | 2026-04-03 |
| Marton Laurence | — | — | 2026-03-20 |
|
Bagai Shaun
Chief Executive Officer
|
— | — | 2026-04-03 |
|
Agah Ramtin
Chief Medical Officer
|
— | — | 2026-04-03 |
|
Gentry Leesa
Chief Clinical Officer
|
— | — | 2026-04-03 |